In the Xiangya cohort, we observed a negative correlation between ACSM6 expression and several critical steps in the cancer immune cycle, which was consistent with our findings (Figure 7A), suggesting that when ACSM6 is highly expressed, TIL infiltration in TME is downregulated (Figure 7B). This evidence concerns the gene ACSM6 and cancer.